Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
stock ticker
|
| gptkbp:CEO |
gptkb:Grant_Pickering
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:CUSIP |
92243G108
|
| gptkbp:focus |
vaccine development
|
| gptkbp:foundedYear |
2013
|
| gptkbp:hasCompany |
Vaxcyte, Inc.
|
| gptkbp:headquartersLocation |
gptkb:San_Carlos,_California,_United_States
|
| gptkbp:heldBy |
US92243G1085
|
| https://www.w3.org/2000/01/rdf-schema#label |
PCVX
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:products |
gptkb:PCV10
gptkb:PCV15 gptkb:PCV20 |
| gptkbp:refersTo |
Vaxcyte, Inc.
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:website |
https://www.vaxcyte.com/
|
| gptkbp:bfsParent |
gptkb:Vaxcyte
|
| gptkbp:bfsLayer |
7
|